Journal of Biomedical Science and Engineering

Volume 5, Issue 1 (January 2012)

ISSN Print: 1937-6871   ISSN Online: 1937-688X

Google-based Impact Factor: 0.66  Citations  h5-index & Ranking

Molecular interactions between anticancer drugs and iodinated contrast media: An in vitro spectroscopic study

HTML  Download Download as PDF (Size: 957KB)  PP. 24-33  
DOI: 10.4236/jbise.2012.51004    6,349 Downloads   11,001 Views  Citations

Affiliation(s)

.

ABSTRACT

Purpose: The purpose of this study is to assess molecular interactions between several anticancer drugs and an iodinated contrast medium by Fourier transform infrared spectroscopy (FT-IR) and ultraviolet-visible spectroscopy (UV-Vis). Materials and Methods: Iopamidol (IPM) was used as an iodinated contrast medium, and mitomycin C (MTI), epirubicin hydrochloride (EPI), cisplatin (CDDP), 5-fluorouracil (5FU), irinotecan hydrochloride (CPT11), gemcitabine hydrochloride (dFdC), carboplatin (CBDCA), oxaliplatin (1OHP), paclitaxel hydrochloride (TAX) and docetaxel trihydrate (TXT) were used as anticancer drugs. For FT-IR, the purified IPM was mixed stoichiometrically with each anticancer drug as well as with a combination of MTI and EPI. After measuring each separated sample and the mixtures, the spectra of the mixtures were compared with the spectra of the sum of pure samples or the combination. For UV-Vis, IPM and anticancer drugs were dissolved in pure water; subsequently for the titration experiments, the mixtures were prepared by varying the molar ratio. IR absorption corresponds to stretching vibrations between atoms having covalent bonding, whereas UV-Vis spectra depend on molecular dynamics and shapes. Both UV-Vis and IR spectra change when there are molecular interactions such as aromatic ring stacking and hydrogen bonding. Result: IPM exhibited molecular interactions with MTI, EPI, CDDP, dFdC, CBDCA, 1OHP, TAX and TXT, as well as with the combination of MTI and EPI on FT-IR. However, molecular interactions were not observed on UV-Vis. Conclusion: Several anticancer drugs have molecular interactions with IPM, which could be clinically utilized for superselective intraarterial infusion chemotherapy.

Share and Cite:

Ishii, R. , Mori, H. , Matsumura, K. , Hongo, N. , Kiyosue, H. , Matsumoto, S. , Yoshimi, T. and Ujiie, S. (2012) Molecular interactions between anticancer drugs and iodinated contrast media: An in vitro spectroscopic study. Journal of Biomedical Science and Engineering, 5, 24-33. doi: 10.4236/jbise.2012.51004.

Cited by

[1] Arterial Administration of DNA Crosslinking Agents with Restraint of Homologous Recombination Repair by Intravenous Low-Dose Gemcitabine Is Effective for Locally …
Cancers, 2022
[2] A novel amphiphilic oligopeptide induced the intrafibrillar mineralisation via interacting with collagen and minerals
2020
[3] Perylene supported metal free brønsted acid-functionalized porphyrin intertwined with benzimidazolium moiety for enhanced photocatalytic etherification of furfuryl …
2020
[4] Adsorption Mechanisms of Gemcitabine Molecules on the Surface of Fe3O4 Nanoparticles with Biocompatible Coatings
2020
[5] Synergistic effect of (3-Aminopropyl) Trimethoxysilane treated ZnO and corundum nanoparticles under UV-irradiation on UV-cutoff and IR-absorption spectra of acrylic …
Polymer Degradation and Stability, 2018
[6] Occurrences, mechanism of action, structural activity relationship and various pharmacological activities of thiadiazole and their derivatives
Review Journal of Chemistry, 2016
[7] A highly sensitive NADH biosensor using nitrogen doped graphene modified electrodes
Journal of Electroanalytical Chemistry, 2016
[8] Hydrothermal synthesis of nitrogen doped graphene nanosheets from carbon nanosheets with enhanced electrocatalytic properties
RSC Advances, 2015
[9] Nano-Structured Films on Optical Fibres as Chemical Sensors and Actuators
2015
[10] Nitric oxide-and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer
Journal of Inorganic Biochemistry, 2015
[11] Chemoradiotherapeutic wrinkled mesoporous silica nanoparticles for use in cancer therapy
APL Materials, 2014

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.